0001162194-22-000061.txt : 20220523 0001162194-22-000061.hdr.sgml : 20220523 20220523201631 ACCESSION NUMBER: 0001162194-22-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220520 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kreger Bradley Allen CENTRAL INDEX KEY: 0001739205 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 22953544 MAIL ADDRESS: STREET 1: C/O FLUIDIGM CORPORATION STREET 2: 7000 SHORELINE COURT, SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC. CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLUIDIGM CORP DATE OF NAME CHANGE: 20011113 4 1 wf-form4_165335137558591.xml FORM 4 X0306 4 2022-05-20 0 0001162194 STANDARD BIOTOOLS INC. LAB 0001739205 Kreger Bradley Allen C/O STANDARD BIOTOOLS INC. 2 TOWER PLACE, STE 2000 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP, Global Operations Common Stock 2022-05-20 4 M 0 3125 0 A 94433 D Common Stock 2022-05-20 4 M 0 2237 0 A 96670 D Common Stock 2022-05-20 4 M 0 2391 0 A 99061 D Common Stock 2022-05-20 4 M 0 25000 0 A 124061 D Common Stock 2022-05-20 4 M 0 9527 0 A 133588 D Common Stock 2022-05-20 4 F 0 14431 2.05 D 119157 D Restricted Stock Units 2022-05-20 4 M 0 3125 0 D Common Stock 3125.0 0 D Restricted Stock Units 2022-05-20 4 M 0 2237 0 D Common Stock 2237.0 6711 D Restricted Stock Units 2022-05-20 4 M 0 2391 0 D Common Stock 2391.0 16735 D Restricted Stock Units 2022-05-20 4 M 0 25000 0 D Common Stock 25000.0 25000 D Restricted Stock Units 2022-05-20 4 M 0 9527 0 D Common Stock 9527.0 28584 D Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter. On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. /s/ Bradley Kreger by Nicholas Khadder, Attorney-in-Fact 2022-05-23